Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Candel Therapeutics Inc (NASDAQ: CADL) closed at $7.81 in the last session, up 9.23% from day before closing price of $7.15. In other words, the price has increased by $9.23 from its previous closing price. On the day, 0.98 million shares were traded.
Ratios:
We take a closer look at CADL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 02, 2022, initiated with a Buy rating and assigned the stock a target price of $11.
On November 19, 2021, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $18.
On August 23, 2021, UBS started tracking the stock assigning a Buy rating and target price of $9.UBS initiated its Buy rating on August 23, 2021, with a $9 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 15 ’25 when Barone Francesca sold 13,534 shares for $7.22 per share. The transaction valued at 97,783 led to the insider holds 110,673 shares of the business.
Tyagarajan Seshu sold 14,322 shares of CADL for $103,476 on Jan 15 ’25. The Chief Technology Officer now owns 96,790 shares after completing the transaction at $7.22 per share. On Jan 15 ’25, another insider, Schoch Charles, who serves as the insider of the company, sold 9,511 shares for $7.22 each. As a result, the insider received 68,717 and left with 43,038 shares of the company.
Stock Price History:
Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is 12.79%, while the 200-Day Moving Average is calculated to be 15.79%.
Shares Statistics:
A total of 44.48M shares are outstanding, with a floating share count of 32.34M. Insiders hold about 27.29% of the company’s shares, while institutions hold 16.18% stake in the company.
